Objectives: The three centers in this study have different policies regarding cerebral perfusion pressure targets and use of vasopressors in traumatic brain injury patients. The aim was to determine if the different policies affected the estimation of cerebral perfusion pressure which optimizes the strength of cerebral autoregulation, termed "optimal cerebral perfusion pressure. " Design: Retrospective analysis of prospectively collected data. Setting: Three neurocritical care units at university hospitals in Cambridge, United Kingdom, Groningen, the Netherlands, and Uppsala, Sweden.
T he management of cerebral perfusion pressure (CPP) in traumatic brain injury (TBI) patients varies in different neurosurgical centers due to inconclusive and conflicting evidence regarding the effects of pharmacologically adjusting CPP. In 1996 (1) and again in 2000 (2) , the Brain Trauma Foundation (BTF) suggested maintaining CPP over 70 mm Hg as a treatment "option," which was their weakest recommendation level. In 2007 (3), the BTF revised the recommended CPP range to 50-70 mm Hg, so that the previous lower limit became an upper limit. This change was motivated primarily by concerns about the possible negative systemic effects of vasopressors (4) . Recently, in 2016 (5), the recommendation was again changed to either 60 or 70 mm Hg as a lower limit depending on the individual patient. Because this change was based on a single-center study from Cambridge (6) , the BTF added the caveat that the specific TBI treatment protocol at that site may have influenced the results. This is a significant point, since a study involving two centers (Edinburgh and Uppsala) with different CPP treatment strategies found that the differences led to radically different relationships between CPP levels and functional outcome (7) . In the center practicing aggressive CPP management, CPP below 70 mm Hg was strongly associated with poor outcome, but in the other center, lower CPP (50-60 mm Hg) was associated with good outcome. Both the 2007 and 2016 editions of the BTF Guidelines emphasized the importance of considering a patient's autoregulation status in determining the appropriate individual CPP level but did not specify a method.
A promising approach is to optimize CPP (CPPopt) (8-11) individually and continuously based on the pressure reactivity index (PRx). PRx is computed as the correlation of the slow waves of mean arterial pressure (MAP) and intracranial pressure (ICP) and is well validated as an index of cerebrovascular pressure reactivity in severe TBI patients (12) (13) (14) . As such, it is a good surrogate for the general health, responsiveness, and functional integrity of the cerebral vessels. Since PRx and CPPopt are computed using only the ICP and MAP waveforms, they can be made available continuously as part of routine monitoring. In retrospective TBI studies, divergence from CPPopt has been found to be associated with unfavorable outcome (8, 9) .
The aim of this observational study was to determine the effects of treatment differences on the estimation of CPPopt in three academic neurosurgical centers with differing CPP treatment protocols and to determine the extent to which the protocols are adhered to in clinical practice.
MATERIALS AND METHODS

Patient Material
A total of 104 TBI patients admitted to our neurosurgical units between May 1, 2012, and April 31, 2015 were included: 35 each from Cambridge and Groningen and 34 from Uppsala. The only requirement was at least 6 hours of continuous computerized ICP and MAP data collected during the first four days of intensive care. Admission and outcome characteristics for the three cohorts are summarized in Table 1 (rows [1] [2] [3] [4] . Clinical status at admission was assessed using the Glasgow Coma Scale (GCS) and outcome at 6 months using the Glasgow Outcome Scale (GOS) by outpatient or telephone interview. CT scans were used to classify injuries as focal or diffuse.
Physiologic Monitoring
ICP was monitored in Cambridge using an intraparenchymal sensor (Codman Microsensor, Integra Life Sciences, Plainsboro, NJ). In Groningen, an intraventricular sensor system with optional cerebral spinal fluid (CSF) drainage (Raumedic Neurovent, Raumedic A.G., Germany) was used in all patients. In Uppsala, either an external ventricular drain (EVD) system (Smith Medical Hanni-Set pressure transducer; Smith Medical, Germany) or the Codman was used. Twenty Uppsala patients were monitored using an intraparenchymal sensor, six with an EVD, and eight with both.
Physiologic data were acquired using the Intensive Care Monitoring (ICM+) software (University of Cambridge, Cambridge, UK) (15) in Cambridge and Groningen and the Odin Software (7) in Uppsala. All variables reported were calculated within the first 4 days of monitoring in intensive care. All patients had more than 7 hours of CPP data during this period, with a median duration of CPP monitoring of 85 hours and interquartile range (IQR) of 68-93 hours.
CPP was measured similarly in the three centers. Blood pressure was zeroed at the level of the right atrium. If possible, the head was elevated at an angle of 30° in Uppsala, and 30-45° in Cambridge and Groningen. CPPopt was calculated according to the algorithm described by Aries et al (9) .
Local Treatment Protocol Differences
Cambridge (16) and Uppsala (17) have published their protocols. All three centers tried to keep ICP less than 20 mm Hg. Cambridge aimed to maintain CPP greater than or equal to 60 or preferably greater than or equal to 70, Groningen's goal was to keep CPP between 50 and 70, and Uppsala CPP greater than or equal to 60 or greater than or equal to 50 mm Hg in the case of thiopental treatment. CPPopt curves were available in Cambridge on bedside computers, but there were no specific CPPopt guidelines.
Cambridge and Groningen used vasopressors (mainly norepinephrine) and fluids to control MAP and CPP. Uppsala largely avoided the use of vasopressors, and when used, it was to treat MAP. Unlike Uppsala and Groningen, Cambridge added neuromuscular blocking agents (atracurium) as part of the first-tier treatment for intracranial hypertension.
In Cambridge and Groningen, sedation and analgesia were based on the use of opiates (fentanyl or morphine), propofol (maximum 4 mg/kg/hr), and midazolam. In Uppsala, propofol was used for sedation (Propolipid; Fresenius Kabi AB, Uppsala, Sweden) in the range of 0-4 mg/kg/hr, and morphine (Morfin; Meda AB, Solna, Sweden) was administered as needed for analgesia.
CSF drainage was rarely used in Cambridge, and not at all in the patients included in this study. Both Groningen and Uppsala used it fairly frequently, intermittently early, and possibly continuous drainage later.
Cambridge never used thiopental and used decompressive craniectomies relatively frequently. Groningen and Uppsala
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Statistical Analysis
Adherence to local CPP protocols was evaluated by computing the percentage of recorded CPP values that were within the range specified by the protocol.
We calculated the percentage of monitoring time for CPP for which a valid CPPopt curve could be computed. CPPopt curves were considered valid if they met the requirements defined by Aries et al (9) . The mean absolute deviation of CPP from CPPopt was calculated, separately for periods above and below CPPopt and for the total duration. The percentage of CPP values more than 5 mm Hg above and below CPPopt were calculated.
To summarize the relationship between CPP and PRx, 1-hour averages of CPP and PRx were calculated for all patients and combined into summary CPPopt curves for each center.
Correlations are Spearman rank correlation test, R. Groups were compared using the Mann-Whitney U Test. Paired comparisons were evaluated with the Wilcoxon signed-rank test. The threshold for statistical significance was 0.05.
Ethical Permission
The local ethical committees in Cambridge, Uppsala, and Groningen granted permission for this study.
RESULTS
Admission and Outcome Data
Uppsala patients tended to be older than in Cambridge or Groningen (Table 1 , row 1). Otherwise, the only significant difference was that no Groningen patients had focal injuries, compared with 10 Cambridge and 12 Uppsala patients. This was due to a policy in Groningen not to insert ICP monitors in patients with focal injuries, since they would be monitored via follow-up CT scans.
Physiologic Variables
Summaries of patient physiology are shown in Table 1 (rows 5-15). ICP was well controlled in all centers. Cambridge had higher MAP values than Groningen or Uppsala. CPP was lowest in Groningen. The variability of MAP and of CPP was greatest in Uppsala. PRx was significantly lower in Groningen than in Cambridge or Uppsala. 
Adherence to Local CPP Protocols
The percentage of monitoring time with CPP within specified ranges was computed for each patient in the study and shown as median/IQR over the patients in 
Last-Tier Treatment
In Cambridge, seven of the 35 patients had secondary decompressions, as did three of the 35 Groningen patients and two of the 34 Uppsala patients. Two Groningen patients and one Uppsala patient had thiopental treatment with continuous electroencephalography monitoring.
CPPopt Metrics
CPPopt was significantly lower for the Groningen patients than Cambridge patients (p < 0.001) ( Table 2 , row 1). The mean absolute CPP/CPPopt difference was greater in Uppsala than in Cambridge (p = 0.002) or Groningen (p = 0.003) ( Table 2 , row 2). There were no significant differences between centers in the percentage of CPP monitoring time with a valid CPPopt ( Table 2 , row 8).
The absolute deviation of actual CPP from CPPopt was greatest in Uppsala (p ≤ 0.001) ( Table 2 , row 2). There were no significant differences between the percentages of monitoring time high side (> CPPopt) versus low side (< CPPopt) with CPP/ CPPopt difference greater than ±5 mm Hg, either within centers or between centers (Table 2, rows 3 and 5). The magnitude of the high-side deviation in Uppsala was greater than low side (p = 0.03) ( Table 2 , rows 4 and 6) and also greater than high-side deviation in the other two centers (Table 2 , row 4). There were no between-center differences in low-side deviation (Table 2, row 6).
The patients with focal injuries had a median CPPopt of 76 (73-82) and the diffuse group median 76 (71-79).
Summary CPPopt Graphs
U-shaped curves with valid CPPopt values were obtained for Groningen (Fig. 1A) and Cambridge (Fig. 1B) , but not for Uppsala (Fig. 1C) .
Summary CPPopt curves were also generated for the younger (< 30 yr) cohorts and older (≥ 50 yr) cohorts in each center (Supplemental Fig. 1 CPPopt Curves were computed for the focal and diffuse injury patient groups. These showed similar patterns with a CPPopt of 79 for the focal group and 80 for diffuse.
Admission Status, Physiology, and Outcome
Significant correlation results are given in Table 3 . The only variable we studied that was significantly correlated with outcome (GOS) was admission GCS (R = 0.263).
Patient Physiology and CPPopt
Mean 4-day CPPopt was highly correlated with CPP (Table 3, Table 1 .
Critical Care Medicine www.ccmjournal.org e239 also computed for each patient, with the median correlation being 0.366 (0.187-0.537). CPP variability (mean absolute deviation from a 4-hr moving average) was highly correlated with the absolute difference between CPP and CPPopt (R = 0.781). CPP variability was in turn highly correlated with MAP variability (R = 0.868), which was correlated with patient age (R = 0.295). Older age was also associated with higher CPP, higher PRx, and greater deviation of actual CPP from optimal CPP, especially on the high side.
DISCUSSION Adherence to Local CPP Protocols
The results presented in Table 1 (rows 5-9) show good adherence to the lower CPP thresholds. In contrast, the upper limit of 70 mm Hg in the Groningen was exceeded 63% of the time in the median case. This is probably explained by the sudden change in the 2007 BTF Guidelines, where the previous lower limit of 70 became an upper limit. Groningen follows these Guidelines. It appears that clinicians in Groningen treated the lower threshold of 50 as a hard limit, but the upper threshold as more of a suggestion. The percentage of monitoring time over 70 was significantly lower in Groningen than in Cambridge (p < 0.001) or Uppsala (p = 0.007), so it appears that the upper threshold did have an effect.
Between-Center Variation in CPPopt
CPPopt was probably lower in Groningen because CPP was lower (Table 1 , row 13), and CPPopt is correlated with actual (Table 3 , row 6). This is because older age is associated with increased MAP variability ( Table 3 , row 5), which is the primary driver of CPP variability (Table 3 , row 9), which is in turn associated with greater deviation from CPPopt (Table 3 , row 11).
Aging is known to be associated with systemic hypertension and increased blood pressure variability, probably caused by stiffening of the arteries (18, 19) . Our results suggest that in the older patients, these factors led to less stable CPP and greater divergence from optimal CPP, especially on the high side.
Our results show very little difference between the diffuse and focal injury patient groups in the computation of CPPopt, so the absence of focal injuries in the Groningen cohort does not seem to have influenced our results.
Summary CPP Optimization Curves
Although Groningen and Cambridge have U-shaped summary curves consistent with previous results, Uppsala shows little variation in PRx relative to CPP, and CPPopt could not be identified (Fig. 1) . We believe that this anomaly is related to the older age of the Uppsala cohort.
In the younger patients (Supplemental 
Clinical Implications
The only effect of CPP treatment on the computation or interpretation of CPPopt identified in this study was that, since CPPopt is limited to the range of observed CPP values, the effect of treatment on CPP tends to have a similar effect on CPPopt. Nevertheless, the three centers had similar median estimates of optimal CPP, ranging from 73 to 79 mm Hg ( Table 2 , row 1).
The small magnitude of these differences is a promising sign for the clinical utility and validity of the CPPopt methodology.
Another clinical consideration is the effect of patient age. Older patients tend to have greater divergence from CPPopt, but in many older patients, the CPPopt curve flattens out, so this divergence has little effect on PRx (Supplemental Fig. 1 , E and F, Supplemental Digital Content 1, http://links.lww.com/ CCM/D146). As discussed above, this is probably due to arterial stiffness, which is more prevalent in older patients.
Confounding Effects of Age and Severity of Injury
We found no correlations with outcome of age, PRx, or deviation of CPP from CPPopt, possibly because in these patients, age was correlated with GCS at admission (R = 0.269, p = 0.006), so that older age was associated with less severe injury. Since older age was also associated with higher (worse) PRx (Table 3 , row 4) and with larger deviation from CPPopt (Table 3 , row 6), the association of older age with less severe injury may have confounded the expected correlations with outcome.
Limitations of This Study
The major limitation of this retrospective study was the lack of detailed, quantitative data regarding therapy and therapy intensity.
CONCLUSIONS
Important heterogeneity regarding CPPopt was found between centers. This may be attributed to different management protocols, especially different CPP targets, and different demographic factors (like age). These factors should be considered when a multicenter randomized study of optimal CPP versus fixed CPP limits trial is conducted.
